Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer

Published:2015-01 Issue:4 Volume:290 Page:2024-2033
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Shao Chen,Ahmad Nihal,Hodges Kurt,Kuang Shihuan,Ratliff Tim,Liu Xiaoqi

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference48 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J. Clin,2008

2. Clinical experience with intermittent androgen suppression in prostate cancer: minimum of 3 years' follow-up;Goldenberg;Mol. Urol,1999

3. Intermittent androgen suppression for prostate cancer: Canadian Prospective Trial and related observations;Bruchovsky;Mol. Urol,2000

4. Intermittent androgen suppression for prostate cancer: rationale and clinical experience;Gleave;Prostate Cancer Prostatic Dis,1998

5. Metformin: an update;Kirpichnikov;Ann. Int. Med,2002

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin: A Dual-Role Player in Cancer Treatment and Prevention;International Journal of Molecular Sciences;2024-04-06

2. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression;Heliyon;2024-02

3. Mitotic Kinase Inhibitors as Therapeutic Interventions for Prostate Cancer: Evidence from In Vitro Studies;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-12

4. Antitumor Effects of Poplar Propolis on DLBCL SU-DHL-2 Cells;Foods;2023-01-07

5. Exogenous proline enhances susceptibility of NSCLC to cisplatin via metabolic reprogramming and PLK1-mediated cell cycle arrest;Frontiers in Pharmacology;2022-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3